KFDA rating drug makers revealed poor GMP management.

Published: 2006-03-16 06:57:00

Updated: 2006-03-16 06:57:00

The KFDA's drug maker rating report last year showed that "A" and "B" graded companies were only 16 and 17 respectively, indicating not so many outstanding or fair drug makers as expected.

The rating report by dosage forms revealed 274 preparations of "C" grade out of the total 560 preparation...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK